Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma
JT Topham, DJ Renouf… - Therapeutic Advances in …, 2023 - journals.sagepub.com
Over a decade of sequencing-based genomics research has unveiled a diverse somatic
mutation landscape across patients with pancreatic ductal adenocarcinoma (PDAC), and the …
mutation landscape across patients with pancreatic ductal adenocarcinoma (PDAC), and the …
[HTML][HTML] Average treatment effect of facility hepatopancreatobiliary cancer volume on survival of non-resected pancreatic adenocarcinoma
Background To examine the average treatment effect of hepato-pancreato-biliary (HPB)
cancer volume on survival outcomes of patients with non-resected pancreatic …
cancer volume on survival outcomes of patients with non-resected pancreatic …
Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort
GS Roth, Y Fayet, S Benmameche-Medjahed… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic cancer is often diagnosed at an advanced stage, complicated
to manage, and highly lethal due to its aggressivity. Optimizing its diagnosis and care …
to manage, and highly lethal due to its aggressivity. Optimizing its diagnosis and care …
Nationwide trends over 10 years in epidemiology and management of pancreatic ductal adenocarcinoma: A real-world study from the French administrative database
L Mas, C Castelli, A Coffy, B Tretarre… - Clinics and Research in …, 2024 - Elsevier
Background & aims Significant progress has been made in the management of pancreatic
ductal adenocarcinoma (PDAC) in recent years. In this population-based study, we aimed to …
ductal adenocarcinoma (PDAC) in recent years. In this population-based study, we aimed to …
Epidemiological, treatment modalities and survival trends in pancreatic cancer. PAPRICAP study
L Mas, JB Bachet - Hépato-Gastro & Oncologie Digestive, 2024 - jle.com
▼ Abstract The incidence of pancreatic ductal adenocarcinoma (PA) is increasing in
developed countries. Significant progress has been made in recent years in the …
developed countries. Significant progress has been made in recent years in the …
Évolutions épidémiologiques, des modalités de traitement et de survie du cancer du pancréas. Étude PAPRICAP
L Mas, JB Bachet - Hépato-Gastro & Oncologie Digestive, 2024 - stm.cairn.info
1 L'adénocarcinome canalaire du pancréas (AP), dont l'incidence augmente dans les pays
développés et en France notamment, fait partie des tumeurs au pronostic le plus réservé [1 …
développés et en France notamment, fait partie des tumeurs au pronostic le plus réservé [1 …
ADVANCES IN GERONTOLOGY
RM PAHLEWI, DW SETYOWATI - ADVANCES IN GERONTOLOGY …, 2022 - elibrary.ru
The final process in human life has many changes, commonly referred to as wreda or the
aging process. This study aims to find out, describe, and analyze techniques for applying …
aging process. This study aims to find out, describe, and analyze techniques for applying …